Under forsøg på at overvinde den øgede eksponering ved at øge dosis af andre proteasehæmmere sammen med ritonavir, sås en høj frekvens af leverreaktioner.
During attempts to overcome the decreased exposure by increasing the dose of other protease inhibitors with ritonavir, a high frequency of liver reactions was seen.